Literature DB >> 30633380

Epigenetic regulation of myelination in health and disease.

Guozhen Lu1, Ming Zhang1, Jian Wang1, Kaixiang Zhang1, Shengxi Wu1, Xianghui Zhao1.   

Abstract

Myelin is lipid-rich structure that is necessary to avoid leakage of electric signals and to ensure saltatory impulse conduction along axons. Oligodendrocytes in central nervous system (CNS) and Schwann cells in peripheral nervous system (PNS) are responsible for myelin formation. Axonal demyelination after injury or diseases greatly impairs normal nervous system function. Therefore, understanding how the myelination process is programmed, coordinated, and maintained is crucial for developing therapeutic strategies for remyelination in the nervous system. Epigenetic mechanisms have been recognized as a fundamental contributor in this process. In recent years, histone modification, DNA modification, ATP-dependent chromatin remodeling, and non-coding RNA modulation are very active area of investigation. We will present a conceptual framework that integrates crucial epigenetic mechanisms with the regulation of oligodendrocyte and Schwann cell lineage progression during development and myelin degeneration in pathological conditions. It is anticipated that a refined understanding of the molecular basis of myelination will aid in the development of treatment strategies for debilitating disorders that involve demyelination, such as multiple sclerosis in the CNS and neuropathies in the PNS.
© 2019 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  Schwann cell; epigenetics; myelination; oligodendrocyte; remyelination

Year:  2019        PMID: 30633380     DOI: 10.1111/ejn.14337

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  3 in total

1.  Emerging molecular therapeutic targets for spinal cord injury.

Authors:  Shuo Wang; George M Smith; Michael E Selzer; Shuxin Li
Journal:  Expert Opin Ther Targets       Date:  2019-09-04       Impact factor: 6.902

Review 2.  Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs.

Authors:  Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Iphigenia Kanara; Anastasios N Mavrakis; Julie Pernokas; Mark Pernokas; Carl A Pinkert; Whitney R Powers; Konstantina Sampani; Kosta Steliou; Demetrios G Vavvas; Robert J Zamboni; Krishna Kodukula; Xiaohong Chen
Journal:  Biores Open Access       Date:  2020-03-31

3.  Conditional Loss of BAF (mSWI/SNF) Scaffolding Subunits Affects Specification and Proliferation of Oligodendrocyte Precursors in Developing Mouse Forebrain.

Authors:  Eman Abbas; Mohamed A Hassan; Godwin Sokpor; Kamila Kiszka; Linh Pham; Cemil Kerimoglu; Andre Fischer; Huu Phuc Nguyen; Jochen F Staiger; Tran Tuoc
Journal:  Front Cell Dev Biol       Date:  2021-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.